Have a feature idea you'd love to see implemented? Let us know!

ANRO Alto Neuroscience Inc.

  1. Stocks
  2. Healthcare
  3. NYSE: ANRO

Price (delayed)

$14.36

Market cap

$387.13M

P/E Ratio

N/A

Dividend/share

N/A

EPS

N/A

Enterprise value

$203.57M

We are a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging neurobiology to develop personalized and highly effective treatment options. Building on more than a decade of ...

Highlights
ANRO's quick ratio is down by 24% since the previous quarter
ANRO's equity is down by 7% QoQ
Sector: Healthcare
Industry: Biotechnology
Website: https://www.altoneuroscience.com
Peers: AMGN GILD VRTX REGN

Key stats

What are the main financial stats of ANRO
Market
Shares outstanding
26.96M
Market cap
$387.13M
Enterprise value
$203.57M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2.15
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
N/A
EBIT
N/A
EBITDA
N/A
Free cash flow
N/A
Per share
EPS
N/A
Free cash flow per share
N/A
Book value per share
$6.69
Revenue per share
N/A
TBVPS
$7.33
Balance sheet
Total assets
$197.36M
Total liabilities
$17.58M
Debt
$10.06M
Equity
$179.78M
Working capital
$185.57M
Liquidity
Debt to equity
0.06
Current ratio
19.85
Quick ratio
19.67
Net debt/EBITDA
N/A
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
N/A
Return on equity
N/A
Return on invested capital
N/A
Return on capital employed
N/A
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ANRO stock price

How has the Alto Neuroscience stock price performed over time
Intraday
0.49%
1 week
1.41%
1 month
4.89%
1 year
N/A
YTD
N/A
QTD
25.52%

Financial performance

How have Alto Neuroscience's revenue and profit performed over time
Revenue
N/A
Gross profit
N/A
Operating income
N/A
Net income
N/A
Gross margin
N/A
Net margin
N/A

Growth

What is Alto Neuroscience's growth rate over time

Valuation

What is Alto Neuroscience stock price valuation
P/E
N/A
P/B
2.15
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
ANRO's equity is down by 7% QoQ

Efficiency

How efficient is Alto Neuroscience business performance

Dividends

What is ANRO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ANRO.

Financial health

How did Alto Neuroscience financials performed over time
ANRO's current ratio is down by 24% since the previous quarter
ANRO's quick ratio is down by 24% since the previous quarter
The debt is 94% smaller than the equity
ANRO's debt to equity is up by 20% from the previous quarter
ANRO's equity is down by 7% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.